Sort
50,496 grants matching “lung cancer”
The lineage and function of neuroendocrine cells in lung homeostasis and injury
$387,100Pao-Tien Chuang · University Of California, San Francisco · R01 · FY2014 · HL
Winship Cancer Institute, Emory University
$387,060Emory University · P20 · FY2004 · CA
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
$387,027Adam Joel Bass · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
$387,027Adam Joel Bass · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
$387,027Adam Joel Bass · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer
$386,990University Of Washington · R01 · FY2002 · CA
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$386,971James Kim · Ut Southwestern Medical Center · R01 · FY2021 · CA
NUTRITIONAL INTERVENTION FOR CANCER CACHEXIA
$386,951Metabolic Technologies, Inc. · R44 · FY2001 · CA
Transgenesis and Xenotransplantation
$386,950Jorge A. Piedrahita · North Carolina State University Raleigh · R01 · FY2010 · HL
HIV-Associated Malignancies (HIVAM)
$386,948King Kennard Holmes · University Of Washington · P30 · FY2014 · AI
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
$386,926Mansoor M. Amiji · Northeastern University · U01 · FY2013 · CA
Individualized estimates of treatment benefit from hormone therapy for men with prostate cancer
$386,866Matthew Schipper · University Of Michigan At Ann Arbor · R21 · FY2023 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$386,860Gary Fanger · Rise Therapeutics, Llc · R44 · FY2021 · CA
HIF- 2ALPHA, Hypoxic Gene Regulation, and Angiogenesis
$386,852M. Celeste Simon · University Of Pennsylvania · R01 · FY2008 · HL
Regulation of PD-1 gene expression
$386,850Jeremy M. Boss · Emory University · R01 · FY2014 · AI
Regulation of PD-1 gene expression
$386,850Jeremy M. Boss · Emory University · R01 · FY2017 · AI
Regulation of PD-1 gene expression
$386,850Jeremy M. Boss · Emory University · R01 · FY2015 · AI
Regulation of PD-1 gene expression
$386,850Jeremy M. Boss · Emory University · R01 · FY2016 · AI
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
$386,846Brent Allen Hanks · Duke University · R01 · FY2022 · CA
Targeting the Epigenome for Lung Cancer Therapy
$386,838David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials
$386,816Dale Murray Needham · Johns Hopkins University · R01 · FY2011 · HL
Organic cation transporter 2 and cisplatin nephrotoxicity
$386,808Alexander Sparreboom · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
NHGRI/DIR Microarray Core
$386,794Elaine Ostrander · National Human Genome Research Institute · ZIC · FY2012 · HG
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicity
$386,777Donna D Zhang · University Of Arizona · R01 · FY2010 · ES
Epigenetic Therapy for Thoracic Malignanceis
$386,745David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA